Organization · Type 2 NPI
Pharma Buddies Corp
Specialty Pharmacy · Orlando, FL
NPI number
1922557982
Active
Practice location
1727 Orlando Central Pkwy
Orlando, FL 32809-5732
Fax (407) 822-1921
Specialties and licenses
| Taxonomy | Code | License |
|---|---|---|
| Pharmacy | 333600000X | None listed |
| Community/Retail Pharmacy | 3336C0003X | None listed |
| Specialty Pharmacy Primary | 3336S0011X | PH24647 (FL) |
Specialty Pharmacy: A pharmacy that dispenses generally low volume and high cost medicinal preparations to patients who are undergoing intensive therapies for illnesses that are generally chronic, complex and potentially life threatening. Often these therapies require specialized delivery and administration.
5 other providers at this address
- Elite Rheumatology PLLCRheumatology Physician Orlando, FL NPI 1891609319
- Pharma Buddies CorpMail Order Pharmacy Orlando, FL NPI 1124566120
- Pharma Buddies CorpSpecialty Pharmacy Orlando, FL NPI 1427377605
- Sunshine Specialty Health Care, LLCInfectious Disease Physician Orlando, FL NPI 1043986979
- Sumalatha Nandikonda, MDRheumatology Physician Orlando, FL NPI 1174842017
Other specialty pharmacy providers in Orlando
- Wal-Mart Stores East LPSpecialty Pharmacy Orlando, FL NPI 1013934413
- Accredo Health Group IncSpecialty Pharmacy Orlando, FL NPI 1043309735
- Advanced Care Scripts IncSpecialty Pharmacy Orlando, FL NPI 1063510097
- Life Worth Living Foundation IncSpecialty Pharmacy Orlando, FL NPI 1114317898
- Aids Healthcare FoundationSpecialty Pharmacy Orlando, FL NPI 1164472825
- Prime Therapeutics Pharmacy LLCSpecialty Pharmacy Orlando, FL NPI 1245241884
- Centerwell Pharmacy, Inc.Specialty Pharmacy Orlando, FL NPI 1295433563
- Nashville Pharmacy Services LLCSpecialty Pharmacy Orlando, FL NPI 1306648415
About NPI 1922557982
Pharma Buddies Corp's National Provider Identifier is 1922557982, issued on Sep 30, 2016. The primary taxonomy on file is Specialty Pharmacy (3336S0011X), and the practice location is in Orlando, FL. The record was last updated on Feb 19, 2025.